Raffles Medical Group Ltd Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018; Provides Earnings Guidance for the Year 2018
For the nine months, the company reported revenue of SGD 361,430,000 against SGD 354,588,000 a year ago. Profit from operating activities was SGD 58,378,000 against SGD 56,055,000 a year ago. Profit before tax was SGD 58,226,000 against SGD 56,639,000 a year ago. Profit attributable to owners of the company was SGD 49,113,000 against SGD 48,705,000 a year ago. Basic earnings per share were 2.76 cents against 2.77 cents a year ago. Diluted earnings per share were 2.75 cents against 2.76 cents a year ago. Group net asset value per ordinary share was 42.51 cents against 41.45 cents a year ago. On company basis net asset value per ordinary share was 36.05 cents against 34.36 cents a year ago. Net cash from operating activities was SGD 31,711,000 against SGD 24,486,000 a year ago. Acquisition of intangible assets was SGD 337,000. Purchase of property, plant and equipment was SGD 4,510,000 against SGD 4,316,000 a year ago.
Based on the current economic conditions and barring unforeseen circumstances, the Directors expect the Group to grow and remain profitable in 2018.